IMR Press / FBL / Special Issues / 1409441280987418626

Therapeutic strategies in human RNA virus infections: intervention on inflammatory response and development of anti-viral drug

Submission deadline: 30 June 2022
Special Issue Editors
Zhen Luo
Jinan University, Guangzhou, China
Interests: Viral Infection and Host Innate Immunity; Interaction between Viral Replication and Host Cell; Inflammation and Carcinogenesis
Huahao Fan
Beijing University of Chemical Technology, Beijing, China
Interests: Drug Screening; Immune Escape and Virus Host Interaction Mechanism of Emerging Infectious Diseases (Coronavirus and Enterovirus); Phage Basics and Clinical Application
Special Issue Information

Dear Colleagues,

Families of RNA viruses that are infectious to human, such as the Coronaviridae, Flaviviridae, Filoviridae, and Orthomyxoviridae, collectively have great potential to cause epidemic diseases in human populations. Recently, the pandemic of COVID-19 caused by SARS-CoV-2 and its tendency to mutation has raised the attention of therapies during RNA virus infection. Although the vaccines against many kinds of RNA virus, such as Poliovirus, Enterovirus 71, Influenza A virus, SARS-CoV-2, protect most of human populations from severe infectious diseases, it is urgent and of importance to optimize therapeutic strategies concerned on the adjustment of host inflammation and the control of virus shedding.

In order to effectively deal with the challenge of RNA viruses, it is necessary to continuously utilize various drug targets of both viral structural and non-structural proteins to develop antiviral drugs. In addition, cytokine storm intrigued by virus infection constitutes a risk factor for severe disease course, so the study of the intervention on the cytokine storm or inflammatory response caused by virus invasion in human organism also has a positive effect on antiviral therapeutic strategy.

This special issue welcomes studies focusing on therapeutic strategies in human RNA virus infections, emphasizing on intervention on inflammatory response and development of anti-viral drug. We are looking forward to submission for both original research and review articles that are involved in these themes.

Assoc. Prof. Zhen Luo and Assoc. Prof. Huahao Fan

Guest Editors

Keywords
Therapeutic Strategies
Human RNA Virus Infections
Inflammatory Response
Antiviral Drug Development
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Back to top